针对疼痛占主导地位的肠-大脑相互作用障碍的针对家长的干预措施的演变:研究和临床实践的考虑
Katherine Lamparyk1, Jacklyn Stellway2, Cathleen Turnage2
1Akron Children's Hospital.
Clinical practice in pediatric psychology
|March 4, 2024
概括
针对家长的干预措施对儿童功能性腹痛障碍有希望. 让家长和利益相关者参与是将这些有效策略纳入临床实践的关键,以获得更好的结果.
科学领域:
- 儿科胃肠病学 儿科胃肠病学
- 儿童心理学 儿童心理学
- 行为医学是一种行为医学.
背景情况:
- 儿童的肠-大脑相互作用 (DGBIs) 的功能性腹部疼痛相关障碍是复杂的,受生物心理社会因素的影响.
- 父母的参与越来越被认为是管理儿科DGBI的关键.
- 了解孩子的环境对于有效治疗至关重要.
研究的目的:
- 审查儿童疼痛相关DGBIs的家长向干预措施的发展.
- 为在临床环境中实施这些干预措施提供建议.
- 弥合研究成果与实际应用之间的差距.
主要方法:
- 一项文献综述侧重于针对儿科疼痛相关的DGBI的家长向干预措施.
- 分析影响研究转化为实践的因素.
- 讨论临床应用策略.
主要成果:
- 有证据支持针对儿童DGBI的家长向干预措施.
- 实施的挑战包括医生采购,家长参与和后勤因素.
- 考虑多个照顾者,孩子的年龄和计费是很重要的.
结论:
- 针对DGBI的针对家长的干预措施有越来越多的证据基础.
- 临床实践建议的广泛采用是有限的.
- 建议利益相关者参与并注意细微的应用,以确保成功实施.
相关概念视频
Analgesia and Pain Management
618
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
618
Drugs for Treatment of Diarrhea-Predominant IBS
169
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
169
Chronic Bowel Disorders: Introduction
450
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
450
Chronic Pancreatitis II: Collaborative Care
88
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
88
Irritable Bowel Syndrome I: Introduction
273
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
273
Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127


